Hedley was an outstanding supply chain partner in working together on the Tarceva product launch team. His demonstrated knowledge of supply chain and inventory management was critical to the successful launch of this product worldwide.Marc Trombella - Clinical Supply Chain Manager at BioMarin
Hedley is a results oriented professional with very high work and ethical standards. He is helpful and considered, an excellent team player. Hedley has in-depth knowledge of the supply chain and related disciplines within the pharmaceutical industry.Violeta Marmon Director API Sourcing, Development and Compliance at HUVEPHARMA AD
After only a few chats over Skype, I realized, Hedley is one of the smartest pharmaceutical professional I've known. He rises above the tactical and really gets the importance of need, value proposition, competitive positioning and communications. I look forward to working with him and his group more intimately (and continue to be inspired).Edward Narke, Regulatory Managing Director and Co-Founder, Design Space InPharmatics
Many organisations underestimate the importance of supply chain management and suffer as a result. Hedley is able to see the big picture and communicate the issues while ensuring all the detail (and this is substantial) is managed. An excellent performer that I would whole-heartedly recommend.Tony Weir, CFO UHUK; COO & CFO Ingenix International at United Health Group
Hedley joined British Biotech when the company was planning to commercialise its first product and he quickly established himself as a key member of the team charged with the final development activities. He brought to the company a wealth of experience and quickly made a significant impact by building a supply chain and logistics system from scratch. With his knowledge, charm and wit Hedley was a true professional and a pleasure to work withDr Rod Baker, CMC and regulatory drug development consultant
37 years in the industry but I never saw the production side in this light; I have learned a lot. Rees has a keen eye for what could go wrong in the drug maker's supply chain.James O Reilly, Professor in FDA Law at the University of Cincinnati and Chair of the FDA Committee of the American Bar Association
Hedley Rees' book is a timely antidote to the faddish advice and writing about outsourcing and lean supply chain management that has bedevilled good practice in the industry, and in supply chain management thinking in generalProfessor Andrew Cox, Chairman, Advisory Board, International Institute for Advanced Purchasing & Supply (IIAPS), former Director of the Centre for Business Strategy and Procurement at Birmingham University Business School, the first ever MBA in Strategic Procurement Management.
Very interesting and refreshing approach to drug development. Using supply chain management as a method [Hedley] reviews current industry practice from drug inception to commercialization, spelling out clear limitations and suggesting a number of daring ideas that could dramatically change how new therapeutics are developedJesús Zurdo, Head of Innovation, Biopharma Development, Lonza Biologics